Red 3 Ban is Just the Beginning: How FDA-Regulated Manufacturers Must Prepare for Future FDA Changes
The Red 3 ban is just the beginning. As FDA regulations evolve, procurement teams must shift from reactive to proactive—leveraging data, AI, and strategic sourcing to ensure compliance, cost control, and supply chain resilience. Simfoni’s Strategic Spend Terminal empowers manufacturers...
